ATP7A and neoplasm: The abundance of ATP7A in a variety of tumor cell lines was found to correlate with increased resistance to cisplatin, a widely used chemotherapeutic agent, and tumor transplants deficient in ATP7A were significantly more sensitive to cisplatin chemotherapy than control tumors expressing ATP7A.